Beleave Provides Guidance on Veterans Affairs Canada Coverage
The link to the original content can be found at the end of our message below.
In the past Forimmediaterelease circulated releases distributed through the Cision and PR Newswire system on a complimentary basis and as a service to our readers.
PR Newswire now claims copyright on press releases distributed through the Cision and PR Newswire system.
Their pitch: “Share your brand’s story around the world,” but that’s where it ends. When eTN, as a media outlet for travel and tourism news, tried to publish a release distributed to journalists by PR Newswire, they were told the release must be removed immediately. In addition, PR Newswire threatened eTurboNews with their legal counsel claiming copyright of releases from PR Newswire or Cision circulates on behalf of clients.
Here is the letter received by eTurboNews from a PR Newswire/Cision director:
“Subject: removal request
Please immediately remove the following posting from your site: [website name removed]
PR Newswire distributed this release on behalf of our client [client name removed]
[company name removed] is understandably upset that the release is posted on your site, tagged with Travel & Tourism Industry release: at the start of the text.
As you can see below in the release that we distributed that we did not include any coding or tagging on our end to indicate that the release is relevant to the Travel & Tourism industry: [website link removed]
Please completely remove the posting from your site as soon as possible, and confirm when complete.
Additionally, I am unable to find a licensing agreement between PR Newswire and eTN, or any other associated websites. If you do have a licensing agreement in which PR Newswire has licensed your sites to publish our content, please send a copy to me as soon as possible.
If you do not have a licensing agreement, we request that you remove all PR Newswire content from all of your sites. If I should have our Counsel send an official request, please let me know to whom it should be resent.
Director CISION PR Newswire”
It appears PR Newswire is not only charging a steep amount of money from companies wanting their releases circulated through their system to journalists but also is now trying to license this content as their copyrighted material. eTN receives more than 2,000 story ideas on a daily basis, we don’t rely on PR Newswire for content, and for sure we won’t pay them a licensing fee for a ‘privilege’ to publish such content.
We urge everyone using PR Newswire services to take a look at this article explaining their modus of operation and misleading reports: http://buzz.travel/prn/ .
PR Newswire is now directly competing with publications. This will result in a drastic drop in pick-ups. They are obviously upset with the attention we received for stoties and the visibility we were able to record way ahead of PR Newswire when it comes to our industry segment.
Journalists of any publication should be warned to consider taking content from PR Newswire or Cision.
Therefore, in the future, if you would like us to consider your press releases for publication, you will need to send it to us directly: For more information, visit: www.buzz.travel .
As a courtesy to our readers, you can find the original release content at:
TORONTO, May 16, 2018 /PRNewswire/ – Beleave Inc. (CSE: BE; OTCQX: BLEVF) (“Beleave” or the “Company”) due to an influx of inquiries from patients would like to provide guidance on the previously released Veterans Affairs Canada’s Medical Cannabis Program administered by Medavie Blue Cross.
The program is available to patients though Veterans Affairs Canada only. For prospective patients, please refer to ACMPR guidelines for more information.
For additional patient information please contact Beleave’s Director of Customer Service Anne Whelan either via email at email@example.com or by phone at 905-517-7306
Alternatively, to stay informed please join the company mailing list at www.beleave.com.
Beleave Inc. is a biotech company and Beleave’s wholly-owned subsidiary Beleave Kannabis Corp. (formerly First Access Medical Inc.) is a licensed producer pursuant to the ACMPR. Beleave’s purpose-built facility is located in Hamilton, Ontario.
This news release contains “forward-looking information” within the meaning of applicable securities law (“forward-looking statements”). The use of any of the words “plan”, “anticipate”, “continue”, “estimate”, “expect”, “may”, “will”, “project”, “should”, “believe” and other similar words, or statements that certain events or conditions “may” or “will” occur are intended to identify forward-looking information. These statements are only predictions. Although the Company believes that the expectations and assumptions on which the forward-looking information is based are reasonable, undue reliance should not be placed on the forward-looking information because the Company can give no assurance that they will prove to be correct. Since forward-looking information addresses future events and conditions, by its very nature it involves inherent risks and uncertainties. This information speak only as of the date of this news release. Actual results could differ materially from those currently anticipated due to a number of factors and risks including various risk factors discussed in the Company’s disclosure documents, which can be found under the Company’s profile on www.sedar.com.
View original content with multimedia:http://www.prnewswire.com/news-releases/beleave-provides-guidance-on-veterans-affairs-canada-coverage-300649931.html
SOURCE Beleave Inc.
To post and circulate your own press release on FIR and the eTN Network please click here
Comments are closed here.